Kit is designed to detect and quantify the level of beta Catenin (Total) in fresh or frozen human cell lysates. Cross-reactivity has bee observed in mouse and rat cells. The assay recognizes both natural and recomb. beta Catenin (Total), independent…
Accession number
P35222, Q02248, Q9WU82
Dose range
0.78-50 ng/ml
Sensitivity of the dosage
<0,30 ng
Concentration
0.78 to 50 ng/ml
Conjugate
HRP
Brand
Invitrogen
Kit is designed to detect and quantify the level of beta Catenin (Total) in fresh or frozen human cell lysates. Cross-reactivity has bee observed in mouse and rat cells. The assay recognizes both natural and recomb. beta Catenin (Total), independent…
Kit is designed to detect and quantify the level of beta Catenin (Total) in fresh or frozen human cell lysates. Cross-reactivity has bee observed in mouse and rat cells. The assay recognizes both natural and recomb. beta Catenin (Total), independent of its phosphorylation state. Principle of the method A monoclonal capture antibody specific for beta Catenin (Total) has been coated onto the wells of 96-well plate. During the first incubation, standards of known content and unknown samples are pipetted into the wells and the antigen binds to the immobilized (capture) antibody. After washing, a rabbit antibody specific for the target protein is added to the wells and serves as a detection antibody by binding to the immobilized protein captured during the first incubation. After washing, a HRP labeled anti-rabbit IgG is added. This binds to the detection antibody to complete the four member sandwich. After a third incubation and washing to remove all the unbound enzyme, a substrate solution (TMB) is added, which is acted upon by the bound enzyme to produce color. The intensity of this colored product is directly proportional to the concentration of target protein present in the original specimen and the O.D. can be read on a standard microplate reader. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
Beta-catenine, an adherent junction protein (AA), was originally identified as a component of cell adhesion structures. AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. Beta-catenine interacts with the cytoplasmic domain of cadherin E and binds cadherin E to alpha-catenine, allowing it to mediterrate the anchoring of the E-cadherin complex to the cortical cytoskeleton d'actin. Studies show that beta-catenine also binds to another cytoskeletal complex containing polypose coli protein and adenomatous microtubules and interacts with several signaling pathways that include tyrosine kinases, phosphatases, and Wnt/Wingless. The interaction between beta-catenine, cytoskeletal complexes and signaling pathways can regulate morphogenesis. Beta-catenine is expressed in several types of hair follicle cells, basal and peripheral matrix cells, and in external and internal root layers cells. A pathological role of beta-catenine has been identified in pilosmatrixoma (PTR), medulloblastoma (MDB), colorectal cancer (CRC), ovarian cancer and tumour development. In the nucleus, beta-catenin is used to co-activate a family of Lef/Tcf transcription factors that stimulate transcription of target genes, including those that code cycline D and c-myc that promote cell proliferation. The influence on cell proliferation is the molecular basis of the role of beta-catenine in tumours, especially solid tumours of the breast, colon, liver, lungs, stomach, prostate and skin. Order information
Shipping conditions: Wet ice
Measurement range
Dose range: 0.78-50 ng/ml.
Duration of dosing
Total duration of dosing: 4 hours.
Reproducibility
Coefficient of variation in intradose 4.5%, interdose 6.3%.